Redoxis is a CRO with core expertise and focus on preclinical drug development and efficacy evaluation in models of inflammatory and autoimmune diseases. With the roots in academic research we strive to be up to date with the latest immunology research and are continuously updating our portfolio of models.

Staying connected with academic research is important to us. We have on-going collaborations with academic partners for model development and are members of several EU funded projects aiming at developing standardized models for autoimmune conditions.